top of page
News and views from the Etcembly team
All Posts
Etcembly announces breakthrough in optimising TCR assets
Etcembly Announces Breakthrough in Optimising TCR Assets. Successful Financing Brings in Singapore VC iGlobe Partners.
Dec 14, 20223 min read
Etcembly Appoints Scott Cuthill as Chief Business Officer
Etcembly Appoints Scott Cuthill as Chief Business Officer. The Oxford based company is transforming TCR immunotherapy research.
Mar 15, 20222 min read
Research Complex at Harwell welcomes Etcembly
Research Complex at Harwell is delighted to welcome Etcembly.
Feb 7, 20221 min read
Etcembly establishes new lab & office space at Oxford Science Park
Immune-focused machine learning firm joins leading AI cohort on Park
Feb 7, 20223 min read
Zelluna Immunotherapy AS Announces Exclusive Research Collaboration with Etcembly Limited
Zelluna Immunotherapy AS announces an exclusive research collaboration with Etcembly Ltd to discover...
Feb 7, 20222 min read
Oxford-based machine learning start-up Etcembly secures Private Seed Funding
Founders, Michelle Teng and Jacob Hurst, bring a unique blend of machine learning and immunology expertise to a next generation biotech
Feb 7, 20222 min read
bottom of page